COMMUNIQUÉS West-GlobeNewswire

Getting the Math Right: The Growing Movement to Improve How Medicines Are Valued Will Take Center Stage at ISPOR 2024

03/05/2024 - 15:00

Health Economists and Policy Experts to Highlight Rationale for and Implementation of Generalized Cost-Effectiveness Analysis ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Leading health economists will gather in Atlanta on [...]

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/05/2024 - 14:30

BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of [...]

Ocuphire Pharma to Present at the Aegis Virtual Conference

03/05/2024 - 14:00

FARMINGTON HILLS, Mich., May 03, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and [...]

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

03/05/2024 - 14:00

MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday [...]

Adverum Biotechnologies to Participate in Upcoming May Investor Conferences

03/05/2024 - 14:00

REDWOOD CITY, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular [...]

PDS Biotechnology Announces Details of Virtual KOL Event

03/05/2024 - 14:00

Virtual Webinar Updated VERSATILE-002 Phase 2 Trial Results, Unmet Treatment Needs in Advanced Head and Neck Cancer and Planned Triple Combination Trial to be held May 8, 2024 PRINCETON, N.J., May 03, 2024 (GLOBE [...]

Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success - Updated

03/05/2024 - 14:00

San Antonio, TX, May 03, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would like to thank Jeffrey [...]

Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results

03/05/2024 - 13:30

MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and [...]

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024

03/05/2024 - 13:30

2024 OIS Retina and ARVO meetings are being held in Seattle, Washington BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company [...]

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/05/2024 - 13:30

SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of [...]

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

03/05/2024 - 13:30

CLEVELAND, May 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) (“Abeona” or the “Company”) today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in [...]

MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call

03/05/2024 - 13:30

ROCKVILLE, MD, May 03, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the [...]

10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series

03/05/2024 - 13:07

Ahead Of Cinco De Mayo, 10 Barrel’s Award-Winning Brew Team Introduces Pub Cerveza, A Traditional Mexican Style Lager BEND, Ore., May 03, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. ("10 Barrel Brewing Co." or "10 [...]

Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List

03/05/2024 - 13:00

TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today [...]

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates

03/05/2024 - 13:00

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1 2025 Phase 2a clinical [...]

Rapid Micro Biosystems Reports First Quarter 2024 Financial Results

03/05/2024 - 13:00

Reports first quarter 2024 total revenue of $5.6 million , representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million, representing growth of at [...]

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/05/2024 - 13:00

RESEARCH TRIANGLE PARK, N.C., May 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired [...]

Augmedix to Participate in Upcoming Investor Conferences in May and June 2024

03/05/2024 - 13:00

SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following [...]

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024

03/05/2024 - 13:00

CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company [...]